What is Generate Biomedicines, Inc. 's total equity?

Generate Biomedicines, Inc. (GENB) reported total equity of $514.8M in Q1 2026.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Generate Biomedicines, Inc. GENB Total Equity

Total Equity at other companies

SSR MiningSSRM

$3.63B+14.6%

NNN REITNNN

$4.4B+0.9%

TDS

Telephone and Data SystemsTDS

$4.92B-3.0%

WingstopWING

-$799.17M-11.8%

Axalta Coating SystemsAXTA

$2.42B+16.6%

Skyline ChampionSKY

$1.57B+1.8%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's total equity?: Generate Biomedicines, Inc. (GENB) reported total equity of $514.8M in Q1 2026.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.